Multiple ascending doses of recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results

被引：0
|
作者：
Bonaca, M. [1 ]
George, R. T. [2 ]
Morrow, D. A. [1 ]
Abuhsira, L. [2 ]
She, D. [2 ]
Park, J. G. [1 ]
Hirshberg, B. [2 ]
Sabatine, M. [1 ]
机构：
[1] Brigham & Womens Hosp, Med, Cardiol, Vasc Med, 75 Francis St, Boston, MA 02115 USA
[2] MedImmune, Gaithersburg, MD USA
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
354
引用
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [31] PHASE-1 STUDY OF TOLERANCE TO INCREASING DOSES OF RECOMBINANT DNA HUMAN ALPHA-2 INTERFERON IN PATIENTS WITH ADVANCED MALIGNANT-TUMORS
    BRETAUDEAU, B
    PALANGIE, T
    GIRALT, E
    JOUVE, M
    POUILLART, P
    FALCOFF, E
    FRIDMAN, WH
    MAGDELENAT, H
    DERSTEPANI, L
    LAURENT, T
    SCHWAB, D
    BULLETIN DU CANCER, 1984, 71 (01) : 40 - 49
  • [32] Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-α2a for patients with advanced renal cell carcinoma
    Motzer, RJ
    Rakhit, A
    Thompson, JA
    Nemunaitis, J
    Murphy, BA
    Ellerhorst, J
    Schwartz, LH
    Berg, WJ
    Bukowski, RM
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (04): : 257 - 263
  • [33] INITIAL RESULTS FROM A COHORT IN A PHASE 2A STUDY (GBT440-007) EVALUATING ADOLESCENTS WITH SICKLE CELL DISEASE TREATED WITH MULTIPLE DOSES OF VOXELOTOR, A SICKLE HEMOGLOBIN POLYMERIZATION INHIBITOR
    Hoppe, Carolyn
    Inati, Adlette
    Brown, Clark
    Wang, Winfred
    Hsu, Lewis
    Gordeuk, Victor
    Liem, Robert
    Woods, Gerald
    Piccone, Connie
    Fong, Erica
    Balaratnam, Ganesh
    Dixon, Sandra
    Tonda, Margaret
    Washington, Carla
    Yaron, Yifah
    Lehrer, Josh
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [34] EFFICACY, SAFETY AND TOLERABILITY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN G IN ADULT PATIENTS WITH PRIMARY IMMUNODEFICIENCIES: PHASE 3 STUDY RESULTS
    Stein, Mark
    Wasserman, Richard L.
    Melamed, Isaac
    Rubinstein, Arye
    Puck, Jennifer
    Gupta, Sudhir
    Engl, Werner
    Leibl, Heinz
    McCoy, Barbara
    Yel, Leman
    Schiff, Richard I.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (06) : 727 - 727
  • [35] Initial Results from a Cohort in a Phase 2a Study (GBT440-007) Evaluating Adolescents with Sickle Cell Disease Treated with Multiple Doses of GBT440, a HbS Polymerization Inhibitor
    Hoppe, Carolyn C.
    Inati, Adlette C.
    Brown, Clark
    Wang, Winfred
    Gordeuk, Victor R.
    Liem, Robert
    Woods, Gerald
    Piccone, Connie M.
    Fong, Erica
    Balaratnam, Ganesh
    Dixon, Sandy
    Tonda, Margaret E.
    Washington, Carla B.
    Yaron, Yifah
    Lehrer, Josh
    BLOOD, 2017, 130
  • [36] Initial Results of a Phase 1/2a, Dose Escalation Study of PVX-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)
    Wang, Michael
    Nooka, Ajay K.
    Yee, Andrew J.
    Thomas, Sheeba K.
    O'Donnell, Elizabeth
    Shah, Jatin
    Weber, Donna M.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Avigan, David
    Raje, Noopur
    BLOOD, 2014, 124 (21)
  • [37] Final Results of a Phase 1/2a, Dose Escalation Study of Pvx-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)
    Nooka, Ajay K.
    Wang, Michael
    Yee, Andrew J.
    Thomas, Sheeba K.
    O'Donnell, Elizabeth K.
    Shah, Jatin J.
    Kaufman, Jonathan L.
    Peterkin, Doris
    Lonial, Sagar
    Richardson, Paul G.
    Raje, Noopur
    BLOOD, 2016, 128 (22)
  • [38] Updated Results of a Phase 1/2a, Dose Escalation Study of Pvx-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)
    Nooka, Ajay K.
    Wang, Michael
    Yee, Andrew J.
    Thomas, Sheeba K.
    O'Donnell, Elizabeth K.
    Shah, Jatin J.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Richardson, Paul G.
    Raje, Noopur S.
    BLOOD, 2015, 126 (23)
  • [39] Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study
    Loomba, Rohit
    Lawitz, Eric J.
    Frias, Juan Pablo
    Ortiz-Lasanta, Grisell
    Johansson, Lars
    Franey, Bridgette Boggess
    Morrow, Linda
    Rosenstock, Moti
    Hartsfield, Cynthia L.
    Chen, Chao-Yin
    Tseng, Leo
    Charlton, R. Will
    Mansbach, Hank
    Margalit, Maya
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (02): : 120 - 132
  • [40] A randomized, double-blind, placebo-controlled study of multiple, ascending doses of recombinant human interleukin-12 (rIL-12) in patients with chronic hepatitis C (HCV) who previously failed therapy with interferon (IFN).
    O'Brien, CB
    Moonka, DK
    Henzel, BS
    HEPATOLOGY, 1998, 28 (04) : 574A - 574A
12345